Dyne Therapeutics, Inc. DYN Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s net change in cash?
- Dyne Therapeutics, Inc. (DYN) reported net change in cash of -$140.25M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s net change in cash changed year-over-year?
- Dyne Therapeutics, Inc.'s net change in cash decreased by 481.1% year-over-year, from $36.81M to -$140.25M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s net change in cash?
- Over 2 years (2021 to 2025), Dyne Therapeutics, Inc.'s net change in cash has grown at a 114.5% compound annual growth rate (CAGR), from -$99.63M to $458.35M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.